Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Clin Chem. 2012 Sep 27;58(12):1648–1655. doi: 10.1373/clinchem.2012.188367

Table 1.

Weighted participant characteristics overall and by history of diagnosed diabetes*

Overall, n = 1,719 (SE) History of diabetes, n= 343 (SE) No history of diabetes, n= 1,376 (SE)
Age, y 70.27 (0.16) 70.26 (0.35) 70.27 (0.18)
Male, % 43.21 (1.49) 48.70 (3.46) 42.06 (1.64)
Black, % 20.21 (0.00) 33.26 (0.01) 17.47 (0.00)
History of hypertension, % 70.81 (1.40) 87.33 (2.48) 67.34 (1.60)
Coronary heart disease, % 9.67 (0.82) 16.33 (2.35) 8.27 (0.85)
Chronic kidney disease, %* 27.89 (1.14) 39.87 (3.01) 67.34 (1.60)
Fasting glucose (mg/dL)*** 108.85 (0.74) 137.46 (2.77) 102.84 (0.54)
Hemoglobin A1c (%) 5.82 (0.02) 6.72 (0.09) 5.63 (0.02)
1,5-Anhydroglucitol (μg/mL) 17.03 (0.21) 13.09 (0.51) 17.86 (0.22)
Fructosamine (μmol/L) 237.65 (0.94) 273.07 (3.51) 230.22 (0.71)
Glycated Albumin (%) 14.31 (0.08) 17.70 (0.34) 13.60 (0.05)

Estimates are means or proportions (SE)

*

Diabetes here is based on self-reported history of a physician diagnosis or glucose lowering medication use.

**

Chronic kidney disease was defined as an estimated glomerular filtration rate < 60 mL/min per 1.73m2 or an albumin-to-creatinine ratio of ≥ 30 mg/g. Among participants with chronic kidney disease, the median estimated glomerular filtration rate was 56.4 ml/min per 1.73 m2 (IQR: 48.3, 74.2) and the median albumin-to-creatinine ratio was 27.6 (IQR: 7.7, 61.1).

***

To convert glucose concentrations from mg/dL to mmol/L, multiply by 0.05551